Sorrento Therapeutics Inc (SRNE)
0.015
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Sorrento Therapeutics Cash from Investing (Quarterly): -0.14M for June 30, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -0.14M |
| March 31, 2023 | 1.684M |
| December 31, 2022 | -5.034M |
| September 30, 2022 | -8.092M |
| June 30, 2022 | -1.728M |
| March 31, 2022 | -13.66M |
| December 31, 2021 | -2.205M |
| September 30, 2021 | 5.396M |
| June 30, 2021 | 78.66M |
| March 31, 2021 | -2.006M |
| December 31, 2020 | -11.41M |
| September 30, 2020 | -25.23M |
| June 30, 2020 | -3.261M |
| March 31, 2020 | -0.021M |
| December 31, 2019 | -10.39M |
| September 30, 2019 | -3.256M |
| June 30, 2019 | -2.26M |
| March 31, 2019 | -22.27M |
| December 31, 2018 | -5.447M |
| September 30, 2018 | -12.94M |
| June 30, 2018 | -2.364M |
| March 31, 2018 | -0.448M |
| December 31, 2017 | -1.601M |
| September 30, 2017 | -4.588M |
| June 30, 2017 | -6.179M |
| Date | Value |
|---|---|
| March 31, 2017 | -4.161M |
| December 31, 2016 | -12.41M |
| September 30, 2016 | -2.808M |
| June 30, 2016 | -1.634M |
| March 31, 2016 | -0.596M |
| December 31, 2015 | -1.757M |
| September 30, 2015 | 26.31M |
| June 30, 2015 | -10.16M |
| March 31, 2015 | -1.843M |
| December 31, 2014 | -10.16M |
| September 30, 2014 | -0.235M |
| June 30, 2014 | -0.104M |
| March 31, 2014 | -0.094M |
| December 31, 2013 | 0.241M |
| September 30, 2013 | -0.516M |
| June 30, 2013 | -0.021M |
| March 31, 2013 | -0.207M |
| December 31, 2012 | -0.0569M |
| September 30, 2012 | -0.1804M |
| June 30, 2012 | -0.0852M |
| March 31, 2012 | -0.2255M |
| December 31, 2011 | -0.2411M |
| September 30, 2011 | -0.0615M |
| June 30, 2011 | -0.6133M |
| March 31, 2011 | -0.1358M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-25.23M
Minimum
Sep 2020
78.66M
Maximum
Jun 2021
-0.1738M
Average
-2.26M
Median
Jun 2019
Cash from Investing (Quarterly) Benchmarks
| Scilex Holding Co | -0.167M |
| AIM ImmunoTech Inc | -0.214M |
| Perspective Therapeutics Inc | -0.089M |
| Protalix BioTherapeutics Inc | -0.342M |
| Armata Pharmaceuticals Inc | -2.39M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -55.66M |
| Cash from Financing (Quarterly) | 88.81M |
| Free Cash Flow | -243.21M |
| Free Cash Flow Per Share (Quarterly) | -0.1012 |
| Free Cash Flow to Equity (Quarterly) | -126.87M |
| Free Cash Flow to Firm (Quarterly) | -53.11M |